Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition
Go back to Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition| (NASDAQ: QTRX) | Delayed: 3.16 -0.12 (3.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.28 | 52 Week High | $ | |||
| Open | $3.28 | 52 Week Low | $ | |||
| Day High | $3.35 | P/E | N/A | |||
| Day Low | $3.07 | EPS | $ | |||
| Volume | 562,786 | |||||



